Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity HPV Assay on Anal Specimens

NCT06327568 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06327568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06327568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity HPV Assay on Anal Specimens
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
June 17, 2022
Completion date
June 17, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, anal intraepithelial neoplasia 1, anal intraepithelial neoplasia 2, high-risk cancer